![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Tag: Coronavirus information (COVID-19)
News
CanSino’s Covid-19 vaccine receives approval in Hungary for emergency use
The Hungarian National Institute of Pharmacy and Nutrition has granted approval for the emergency use of Chinese company CanSino Biologics’ Covid-19 vaccine.
Named Convidecia, the...
Press Releases
Catalent Expands Partnership with Johnson to Significantly Increase Capacity for Sterile Manufacturing and Packaging of COVID-19 Vaccine in Italy
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products,...
Clinical Trials
Moderna starts Phase I study of new Covid-19 vaccine candidate
Moderna Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that the first participants have been dosed in the Phase 2/3...
News
AstraZeneca to supply the US with up to half a million additional doses of the potential COVID-19 antibody treatment AZD7442
AstraZeneca has modified an existing agreement with the US Government to supply up to 500,000 additional doses of AZD7442, a long-acting antibody (LAAB) combination...
Drug Research
Tevogen Bio, BioCentriq Partner for COVID T-cell Therapy
Tevogen Bio has entered a partnership with BioCentriq, a New Jersey based cell and gene therapy development and manufacturing center, to support clinical manufacturing...
News
Frost & Sullivan sees decentralization critical to success of Indias Covid-19 vaccination campaign
Union government needs to implement multiple innovative ways to make vaccines easily accessible. decentralization of vaccination is paramount for increasing coverage in urban areas...
News
Biovaxy’s Enters Major Bioproduction Agreement With WuXi Biologics to Synthesize Proteins for Its Sars-CoV-2 Vaccine and Covid-T Immunodiagnostic Programs
BioVaxys Technology Corp., the world leader in haptenized protein vaccines for antiviral and cancer applications, announced today that it has entered into a major...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read